Multiple sclerosis: treatments, associated drugs and conditions
Multiple sclerosis: a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath.
We study 690,386 people who have Multiple sclerosis. The information that eHealthMe analyzes includes:- COVID vaccines that are associated with Multiple sclerosis
- Medications that treat Multiple sclerosis and their effectiveness
- 1,985 drugs that are associated with Multiple sclerosis
- 1,262 conditions that are associated with Multiple sclerosis
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
Number of reports submitted per year:
COVID vaccines that are associated with Multiple sclerosis:
- Multiple sclerosis in Moderna COVID Vaccine
- Multiple sclerosis in Pfizer BioNTech Covid Vaccine
- Multiple sclerosis in Johnson and Johnson Covid Vaccine
Multiple sclerosis treatments and how effective are they?
Common drugs associated with Multiple sclerosis:
All the drugs that are associated with Multiple sclerosis:
- Multiple sclerosis (1,985 drugs)
Common conditions associated with Multiple sclerosis:
All the conditions that are associated with Multiple sclerosis:
- Multiple sclerosis (1,262 conditions)
Browse all Multiple sclerosis symptoms:a b c d e f g h i j k l m n o p q r s t u v w x y z
Do you take any medication?- You can start a phase IV clinical trial to monitor drug safety and effectiveness.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
Related publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
How we gather our data?
Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.
Recent studies on eHealthMe:
- Sertraline Hydrochloride and Peptic Ulcer Haemorrhage - 7 seconds ago
- Decadron and Soft Tissue Infection - 8 seconds ago
- Alphagan and Raynaud'S Phenomenon - 12 seconds ago
- Armodafinil vs. Caffeine - 18 seconds ago
- Colestid and Accupril drug interaction - 22 seconds ago